Elise Tu

Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study

G. Dore, M. van der Valk, S. Barbieri, 2023, Journal of the International AIDS Society.

Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection

G. Cooke, G. Dore, C. Orkin, 2018, Journal of viral hepatitis.